Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1970 Jun;68(2):233–244. doi: 10.1017/s0022172400028709

The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus

Jean C Downie, C H Stuart-Harris
PMCID: PMC2130804  PMID: 5270204

Abstract

Trials were made in volunteers in 1967 and 1968 of various virus vaccines against influenza virus B. Sera and serially collected nasal washings before and after immunization were tested respectively for haemagglutination-inhibiting and tissue culture virus-neutralizing antibodies to the same strain of influenza B/Eng/65 virus as that used in the vaccines. Infection, as determined by recovery of virus and serological changes following intranasal instillation of attenuated live virus, was accompanied by the subsequent appearance of neutralizing antibodies in nasal secretion. Inactivated vaccine subcutaneously did not evoke nasal antibody formation in 1967 but did so in 1968.

In 1968 intranasal challenge of the volunteers with the attenuated virus 1 month after immunization demonstrated a correlation of susceptibility or resistance to infection with nasal and serum antibodies. Resistance appeared to depend either on a high level of serum antibodies or nasal antibodies, or both.

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alford R. H., Rossen R. D., Butler W. T., Kasel J. A. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. J Immunol. 1967 Apr;98(4):724–731. [PubMed] [Google Scholar]
  2. Andrews B. E., Beare A. S., McDonald J. C., Zuckerman A. J., Tyrrell D. A. Further trials of live influenza vaccine. Br Med J. 1966 Mar 12;1(5488):637–640. doi: 10.1136/bmj.1.5488.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRADSTREET C. M., TAYLOR C. E. Technique of complementfixation test applicable to the diagnosis of virus diseases. Mon Bull Minist Health Public Health Lab Serv. 1962 May;21:96–104. [PubMed] [Google Scholar]
  4. Beare A. S., Bynoe M. L., Tyrrell D. A. Investigetion into the attenuation of influenza viruses by serial passage. Br Med J. 1968 Nov 23;4(5629):482–484. doi: 10.1136/bmj.4.5629.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beare A. S., Tyrrell D. A., Hobson D., Howells C. H., Pereira M. S., Pollock T. M., Tyler L. E. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) 1969 Mar;67(1):1–11. doi: 10.1017/s002217240004136x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cate T. R., Rossen R. D., Douglas R. G., Jr, Butler W. T., Couch R. B. The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol. 1966 Sep;84(2):352–363. doi: 10.1093/oxfordjournals.aje.a120648. [DOI] [PubMed] [Google Scholar]
  7. DAVENPORT F. M. Inactivated influenza virus vaccines. Past, present, and future. Am Rev Respir Dis. 1961 Feb;83(2):146–156. doi: 10.1164/arrd.1961.83.2P2.146. [DOI] [PubMed] [Google Scholar]
  8. Fleet W. F., Couch R. B., Cate T. R., Knight V. Homologous and heterologous resistance to rhinovirus common cold. Am J Epidemiol. 1965 Sep;82(2):185–196. doi: 10.1093/oxfordjournals.aje.a120543. [DOI] [PubMed] [Google Scholar]
  9. Francis T., Jr THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS. Science. 1940 Feb 23;91(2356):198–199. doi: 10.1126/science.91.2356.198. [DOI] [PubMed] [Google Scholar]
  10. Francis T., Salk J. E., Pearson H. E., Brown P. N. PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA A. J Clin Invest. 1945 Jul;24(4):536–546. doi: 10.1172/JCI101633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GRESSER I., DULL H. B. A VIRUS INHIBITOR IN PHARYNGEAL WASHINGS FROM PATIENTS WITH INFLUENZA. Proc Soc Exp Biol Med. 1964 Jan;115:192–196. doi: 10.3181/00379727-115-28867. [DOI] [PubMed] [Google Scholar]
  12. Hoyle L., Fairbrother R. W. Isolation of Influenza Virus: The Manchester Epidemic. Br Med J. 1937 Mar 27;1(3977):655–657. doi: 10.1136/bmj.1.3977.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kasel J. A., Fulk R. V., Togo Y., Hornick R. B., Heiner G. G., Dawkins A. T., Jr, Mann J. J. Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature. 1968 May 11;218(5141):594–595. doi: 10.1038/218594a0. [DOI] [PubMed] [Google Scholar]
  14. Kasel J. A., Hume E. B., Fulk R. V., Togo Y., Huber M., Hornick R. B. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol. 1969 Mar;102(3):555–562. [PubMed] [Google Scholar]
  15. LIDWELL O. M., WILLIAMS R. E. The epidemiology of the common cold. II. Cross-infection and immunity. J Hyg (Lond) 1961 Sep;59:321–334. doi: 10.1017/s0022172400038985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mann J. J., Waldman R. H., Togo Y., Heiner G. G., Dawkins A. T., Kasel J. A. Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol. 1968 Apr;100(4):726–735. [PubMed] [Google Scholar]
  17. McDonald J. C., Zuckerman A. J., Beare A. S., Tyrrell D. A. Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J. 1962 Apr 14;1(5284):1036–1042. doi: 10.1136/bmj.1.5284.1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. SIGEL M. M., KITTS A. W. The recurrence of influenza A prime in a boarding school after 2 years. J Immunol. 1950 Jan;64(1):33–38. [PubMed] [Google Scholar]
  19. Salk J. E., Pearson H. E., Brown P. N., Francis T. PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA B. J Clin Invest. 1945 Jul;24(4):547–553. doi: 10.1172/JCI101634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schulman J. L., Khakpour M., Kilbourne E. D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol. 1968 Aug;2(8):778–786. doi: 10.1128/jvi.2.8.778-786.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith C. B., Purcell R. H., Bellanti J. A., Chanock R. M. Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med. 1966 Nov 24;275(21):1145–1152. doi: 10.1056/NEJM196611242752101. [DOI] [PubMed] [Google Scholar]
  22. Tremonti L. P., Lin J. S., Jackson G. G. Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2. J Immunol. 1968 Sep;101(3):572–577. [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES